Microtubule nucleation requires the J-tubulin ring complex, and during the M phase (mitosis) this complex accumulates at the centrosome to support mitotic spindle formation. The posttranslational modification of J-tubulin through ubiquitination is vital for regulating microtubule nucleation and centrosome duplication. Blocking the BRCA1/BARD1-dependent ubiquitination of γ-tubulin causes centrosome amplification. In the present study, we identified BRCA1 associated protein-1 (BAP1) as a deubiquitination enzyme for γ-tubulin. BAP1 was downregulated in metastatic adenocarcinoma breast cell lines compared to non-cancerous human breast epithelial cells. Furthermore, low expression of BAP1 was associated with reduced overall survival of breast cancer patients. Reduced expression of BAP1 in breast cancer cell lines was associated with mitotic abnormalities. Importantly, rescue experiments including expression of full length but not the catalytic mutant of BAP1 reduced ubiquitination of J-tubulin and prevented mitotic defects. Our study uncovers a new mechanism for BAP1 involved in deubiquitination of J-tubulin, which is required to prevent abnormal mitotic spindle formation and genome instability.
Introduction
Post-translational modification of proteins by covalent attachment of ubiquitin controls many essential cellular processes by targeting the proteins for assembly into complexes, transport and degradation (1, 2) . The type of polyubiquitin chains including lysine 48 (K48) versus lysine 63 (K63) or monoubiquitination can induce different signaling pathways that regulate different aspects of cellular functions. The most prominent function of polyubiquitination chains through K48-linkage degrades the substrate through the mechanism of the proteasome, while K63-linked ubiquitin chains add new functional properties to the modified protein, except for proteosomal degradation (1, 2) . Monoubiquitination or multiple monoubiquitination generally leads to transcription regulation as well as DNA repair and cell cycle progression (1, 2) . The action of ubiquitin ligation enzymes responsible for the attachment of the ubiquitin moieties to the substrate is reversed by the action of deubiquitination enzymes (DUB) (3) . The human genome encodes a large number of putative DUBs, and accumulating evidence indicates that most of these enzymes regulate a limited number of proteins (4) . The dysregulation of DUBs function is highly related to human diseases, especially cancer, with examples of hyperactivation or inactivation due to genetic or epigenetic changes. In this aspect, it is vital to identify substrate-specific DUBs to understand the signaling pathways that are dysregulated in cancer cells. Although it is becoming increasingly clear that DUBs play critical roles in various cellular pathways, physiological roles for most of the human DUBs remain unknown.
BRCA1-associated protein-1 (BAP1) is a nuclear-localized DUB that was originally identified as a BRCA1-binding protein in a yeast two-hybrid screen (5) . BAP1 is ubiquitously expressed in different human tissues, especially in the testis, placenta and ovaries, with varying levels detected in other tissues including human breast. In mice, BAP1 expression is upregulated in the breast during puberty and pregnancy (6) . BAP1 belongs to the ubiquitin Cterminal hydrolase (UCH) family of DUBs, and the activity of BAP1 is restricted to the Nterminal UCH domain, which executes binding and cleavage of the ubiquitin isopeptide bond (5) . The BAP1 gene is frequently mutated in lung, breast, melanoma and renal cell carcinoma (5, 7) and overexpression of BAP1 in lung cancer cells reduces both tumor formation in mice and cell growth in culture. It has thus been suggested that BAP1 acts as a tumor suppressor gene (6) . The tumor suppressor property of BAP1 is dependent on its nuclear localization and deubiquitin activity (8) . In MCF7 breast cancer cell lines, it was shown that the binding of BAP1 to breast cancer type 1 susceptibility Protein (BRCA1) enhances BRCA1-mediated growth suppression (5) . However, in contrast to this result, it has been shown that growth suppression is independent of BRCA1 and that BAP1 disrupts the BRCA1/BRCA1 associated ring domain 1 (BARD1) heterodimer, but cannot reverse its auto-ubiquitination (6, 9, 10) . Therefore, the exact role of BAP1 in BRCA1-mediated signaling and functions remains unknown. Host cell factor C1 (HCF-1) is another binding partner for BAP1. HCF-1 is a transcriptional cofactor found in a number of important regulatory complexes and it localizes to chromatin. BAP1 was shown to regulate HCF-1 protein expression leading to changes in gene expression involved in the G1-S transition and cell proliferation (11) .
The eukaryotic function of J-tubulin is highly conserved and includes regulating microtubule nucleation and centrosome duplication (12) . Ubiquitination of J-tubulin at lysines 48 and 344, achieved by the activity of the heterodimeric tumor-suppressor complex BRCA1/BARD1, was shown to be important for microtubule nucleation at the centrosome and centrosomal amplification (13) (14) (15) (16) . As BRCA1/BARD1 promotes ubiquitination of J-tubulin, the DUB responsible for reversing this process in not known.
In the present study, we identify BAP1 as a specific DUB for J-tubulin. Deubiquitination of J-tubulin is an important event in mitosis that regulates mitotic spindle organization and prevents genomic instability. 
Materials and methods

Cell Culture
The human breast cell lines were cultured in 5 days at 37°C and 5% CO2 as follows:
MCF10A cells were cultured in Dulbecco's modified Eagles medium/F12(GIBCO, life technologies, UK), supplemented with 5% horse serum (Sigma Aldrich, Sweden), 20 ng/ml EGF (Sigma Aldrich, Sweden), 100 ng/ml cholera toxin (Sigma Aldrich, Sweden), 0.01 mg/ml insulin, 500 ng/ml hydrocortisone (Sigma Aldrich, Sweden), and 0.1% penicillin/streptomycin (GIBCO, life technologies, UK). The breast cancer cells (MCF7, MDA-MB-231 and MDA-Mb-468) were cultured in RPMI (HyClone, Thermo-scientific, USA), Supplemented with 10% FBS (Sigma Aldrich, Sweden), 0.1% sodium pyruvate (Sigma Aldrich, Sweden), 0.1% penicillin/streptomycin (GIBCO, life technologies, UK).
siRNA DUB screen
MCF10A cells were grown in 6-well plates to 30-50% confluency and then transfected with human DUBs siRNA library (Thermo scientific, USA) at 2µM, using Interferin (Polyplus transfection, USA). After 72 hours, cells were lysed with RIPA buffer. Lysates were subjected to SDS-PAGE followed by immunoblotting with indicated antibodies.
BAP1 mutagenesis
Active-site (C91A) mutation was introduced into BAP1-FLAG by using QuikChange sitedirected mutagenesis (Stratagene, USA) and the following primers: C91A-BAP1-forward, 5′-CACCAGCTGATACCCAACTCTGCTGCAACTCATGCCTTGCTGAG-3' and Reverse, 5′-CTCAGCAAGGCATGAGTTGCAGCAGAGTTGGGTATCAGCTGGTG-3′. 
Live cell imaging
Cell divisions were followed live by real-time scanning laser microscopy. Cells expressing GFP-tagged H2B protein were seeded in 4-wells or 8-wells chamber slides (Lab-Tek, Thermo Scientific, USA) in phenol red-free DMEM medium (HyClone, Thermo-scientific, USA) supplemented with 10% FBS, 2 mM L-glutamine, 100 units/mL penicillin and 100 ug/mL streptomycin (Sigma Aldrich, Sweden). Cells were allowed to attach overnight in a humidified incubator (37°C, 5% CO 2 ) and analyzed the next day using a Zeiss LSM 710 confocal scanning microscope (Carl Zeiss, Germany) in a temperature (37°C) and atmosphere (21% O 2, 5% CO 2 ) -controlled chamber, on a heated stage insert (37°C). Live imaging of division stages were followed using 488-nm laser excitation, 493-598 emission filters and captured with an EC Plan-Neofluar 40x/1.30 Oil DIC M27 objective (Carl Zeiss, Germany) scanning every 30 s over the division time.
Qantitative PCR
The cells were rinsed in cold PBS and total RNA extracted using the Perfect Pure RNA tissue kit (5 PRIME, Germany) according to manufacturer's instruction. The purity of RNA was analyzed and quantified by a NanoDrop spectrophotometer (Saveen Werner, Sweden) and 
Results
Identification of BAP1 in regulating γ-tubulin deubiquitination
In the present study, we aimed to identify the specific DUB responsible for deubiqitination of J-tubulin using the non-cancerous human breast epithelial cell line MCF10A. MCF10A cells were used because J-tubulin can bind and undergo ubiquitination via BRCA1 in breast cells (15); indeed, we found that BRCA1 was co-localized with J-tubulin during prophase in MCF10A cells, but not during metaphase, anaphase or telophase ( Supplementary Fig. S1 ).
Screening an siRNA library of DUBs, we identified BAP1 and UCHL1, by observing an additional band corresponding to the possible di-ubiquitination of J-tubulin (Fig. 1A, B) . Double depletion of BAP1 and UCHL1 resulted in ubiquitination of J-tubulin to the same extent as single depletion (Fig. 1B, last lane) . In addition, we found that BAP1 but not UCHL1 created a connection network with J-tubulin and BRCA1 ( Supplementary Fig. S2 ).
Deconjugation of ubiquitin from γ-tubulin was also confirmed by siRNA oligonucleotides against BAP1 (Fig. 1C) .
Downregulation of BAP1 leads to increased J J-tubulin ubiquitination
Initially, we investigated the total levels of BAP1 in human breast cancer cells (MCF-7,
MDA-MB-231, and MDA-MB-468) and non-cancerous human breast epithelial cells (MCF10A). BAP1 was significantly downregulated at the mRNA ( cellular fractionation and confocal microscopy showed both cytoplasmic and nuclear localization of BAP1 in MCF10A cells ( Supplementary Fig. S3 ). In order to investigate whether BAP1 expression is altered in breast cancer, we studied the association of BAP1 levels with breast cancer patient outcomes. Kaplan-Meier survival analysis using a microarray data set from 2,978 breast cancer patients revealed that high BAP1 expression was significantly associated with better overall survival (p = 3.4e-7) (Fig. 2C) . Further, high BAP1 expression in tissue samples from basal and luminal subtype tumors were significantly associated with prolonged progression-free survival (Fig. 2D , E, and F). Together, in vitro data and patient tumor data suggest that BAP1 expression is inversely correlated with tumor cell aggressiveness. Endogenous immunoprecipitation of J-tubulin in MCF10A cells precipitated BAP1 during mitosis and UCHL1 during G1 cell cycle phase ( Supplementary Fig. S4A ). In addition, we found that BAP1 at the M-phase and UCHL1 at the G1-phase of cell cycle reduce the levels of ubiquitin-associated tubulin compared to S-phase ( Supplementary Fig. S4A ). This suggests that BAP1 and UCHL1 both acting as DUB for J-tubulin but in different phases of the cell cycle. Furthermore, interphase and mitosis synchronized cells, confirmed the interaction between BAP1 and J-tubulin at the M-phase (Fig. 4A) . Since the levels of BAP1 are low in MDA-MB-468 cells (See Fig. 2A and B) , we virally infected these cells with BAP1
( Supplementary Fig. S5 ). Consistent with the MCF10A data, immunoprecipitation of overexpressed BAP1 in MDA-MB-468 cells precipitated J-tubulin during the process of mitosis (Fig. 4B ) and in vitro pulldown experiments using J-tubulin and BAP1 recombinant proteins showed a direct interaction between these two proteins (Fig. 4C) . Furthermore, immunofluorescence staining and confocal microscopy experiments showed co-localization of endogenous J-tubulin and BAP1 during metaphase, anaphase and telophase but not during prophase in MCF10A cells (Fig. 4D) . Overexpression of BAP1 in MDA-MB-468 cells also resulted in a co-localization between exogenous BAP1 and J-tubulin during metaphase, anaphase and telophase (Fig. 4E) . Consistent with the confocal microscopy results, endogenous BAP1 (Fig. 4F ) or overexpressed BAP1 (Fig. 4G ) was efficiently coimmunoprecipitated with J-tubulin during metaphase (M1), anaphase (M2) and telophase (M3) but not during prophase (M0) in cell extracts prepared from different stages of mitosis.
Consistent with these results, γ-tubulin ubiquitination was only detected during prophase (M0) and not during metaphase (M1), anaphase (M2) and telophase (M3) of cell cycle (Fig.   4H ). As expected, we could not find any interaction between UCHL1 and J-tubulin in MCF10A cell extracts prepared from different stages of mitosis ( Supplementary Fig. S4B ).
These results together suggest that a direct interaction between BAP1 and J-tubulin as well as deubiquitination of J-tubulin occurs during metaphase, anaphase and telophase. (Fig. 5B) . Next, we constructed a catalytic inactive mutant of BAP1 by mutation of cysteine a.a. 91 to alanine in the UCH domain of BAP1 (BAP1-C91A) and incubated purified wild-type (BAP1-Wt) or BAP1-C91A with γ-tubulin isolated from MDA-MB-468 cells. Wild-type, but not the catalytic inactive mutant of BAP1-C91A, resulted in significantly decreased J-tubulin ubiquitination in vitro (Fig. 5C ). These data together suggest that BAP1 is a specific DUB for J-tubulin.
BAP1 is necessary for proper mitotic spindle organization and chromosome abnormalities
Since an interaction was observed between BAP1 and J-tubulin during mitosis (see Fig. 4 ), we next investigated whether BAP1 expression can affect proper mitosis. The number of cells harbouring mitotic abnormalities observed in control MDA-MB-468 cells (Figs. 6A, B , and C) was reduced when the cells were stably expressing BAP1 (Fig. 6D) . These abnormalities 
include chromosomes lagging during metaphase, uncondensed mitotic chromosomes, anaphase bridges, telophase bridges, and tripolar mitotic spindles, which are signs of chromosome aberrations (Figs. 6A, B, C, and D) . Figure 6E and 6F summarizes the percentage of these abnormalities comparing BAP1-with empty expression plasmid-infected cells. Importantly, BAP1-C91A-expressing MDA-MB-468 cells did not show any differences in the percentage of different mitotic abnormalities compared with empty expression plasmid-transfected cells (Fig. 6E, F, and G) , suggesting that the deubiquitin activity of BAP1 is necessary for preventing chromosome abnormalities. We could not find any differences in microtubule nucleation and microtubule regrowth in control and BAP1-expressing cells, suggesting that deubiquitination of γ-tubulin by BAP1 is not essential for mitotic spindle formation (Fig. 6H) . Properly anchored and organized microtubules at centrosomes and spindles are prerequisites for proper chromosome segregation, therefore, we investigated whether loss of BAP1 expression causes defects at these stages of mitosis in malignant breast epithelial cells. Immunofluorescent staining and statistical analysis showed significant differences in the number of control cells exhibiting bipolar spindles with misaligned and uncondensed chromosomes with abnormal mitotic spindles compared to BAP1-expressing cells (Fig. 7A and B) . These results suggest that lack of BAP1 expression causes mitotic spindle abnormalities that might contribute to improper chromosome segregation.
The mitotic defects observed in MDA-MB-468 cells with low levels of BAP1 might be indicative of a premature exit from mitosis. This was tested by performing live-cell microscopy using control and BAP1 stably expressing MDA-MB-468 cells, which were transfected with the histone marker GFP-H2B. Control (Fig. 7C and Supplementary Video 1) but not BAP1 expressing cells, showed defects in chromosome condensation and lagging of chromosomes that never correctly progressed to the metaphase plate ( Discussion γ-Tubulin is a member of the tubulin superfamily and is required for nucleating the polymerization of microtubules. γ-Tubulin is mainly located at the centrosome, and the amount of γ-tubulin at the centrosome increases dramatically at the beginning of mitosis and decreases at the end of mitosis (12) . Post-translational modification of J-tubulin by ubiquitination is mediated via the BRCA1/BARD1 complex, which was shown to regulate the centrosome number and aster formation (15). During mitosis, BRCA1 localizes to centrosomes (17, 18) and the BRCA1/BARD1 complex localizes to centrosomes throughout the cell cycle, however, at very low levels during mitosis (19) . Furthermore, disruption of the BRCA1 gene in mice led to centrosome amplification and aneuploidy (20) . Loss of BRCA1 activity, as occurs in breast cancer cells, results in unrestrained centrosomes. This leads to hyperactive and over-duplicated centrosomes often observed in breast cancer cells (15).
In the present study, we aimed to identify the enzyme(s) responsible for reversing ubiquitination of J-tubulin in breast epithelial cells. We screened an siRNA library for DUBs and identified BAP1 and UCHL1. Genetic studies have uncovered that BAP1 mutations are related to different tumor types including malignant mesothelioma (21, 22) , melanocytic tumor, uveal and cutaneous melanoma (7, 23) , as well as lung cancer (24, 25) , and renal carcinoma (26). Restoration of BAP1 inhibits cell growth of non-small lung cell carcinoma cell line NCI-H226 that lacks BAP1 by inducing cell death (6) . In MCF7 breast cancer cell reverse its autoubiquitination (5, 6, 9, 10). Therefore, the exact role of BAP1 in breast cancer is unknown.
To investigate whether BAP1 expression in breast cancer has a prognostic implication, we performed Kaplan-Meier survival analysis using a microarray data set from 2,978 breast cancer patients. High BAP1 expression was associated with better overall survival, and more The MT nucleation rate usually increases at the entry into mitosis. The centrosomal concentration of J-tubulin reached at metaphase and centrosome size increase through anaphase, whereas nucleation remains high through telophase, implying the presence of additional regulatory processes (27) . Furthermore, during mitosis there is a sudden increase of the J-tubulin content in the centrosome (28) , and mitotic centrosomes exhibit enhanced MT nucleation capacity (29) . Therefore, the J-tubulin content in the centrosome regulates MT nucleation function (14) . Previous studies found that ubiquitination of J-tubulin by BRCA1/BARD1 during the S and G2 phases (13, 14) has a significant role in regulating MT nucleation, which further prevents aberrant reduplication of the centrosomes (15). This could imply that J-tubulin ubiquitination directly inhibits centrosome microtubule nucleation function. In addition, during early mitosis, it has been shown that Aurora A kinase (AURKA) localizes to the centrosome and mediates microtubule nucleation activity through phosphorylation and inactivation of BRCA1 (14) .
Deubiquitination enzymes and E3 ligases are often found in a complex together. These interactions allowing the E3 ligase to regulate the target and its deubiquitination enzyme simultaneously or deubiquitination enzyme/E3 ligase interactions confer target specificity, which is strictly dependent on the E3 ligase for recognition of the substrate (4). The present study suggests that the complex interaction between BAP1, BRCA1 and γ-tubulin is essential for deubiquitination of γ-tubulin to allow proper mitotic progression. (n=1463) (D), luminal B (n=805) (E) , and basal (n=402) (F) breast tumor subtypes using a microarray data set from the publically available expression data base for breast cancer (GOBO (http://co.bmc.lu.se/gobo). 
